partnering

News

Catalyst throws lifeline to Santhera with $90m Duchenne deal

Swiss biotech Santhera has found a North American partner for its Duchenne muscular dystrophy (DMD) therapy vamorolone, ahead of an FDA decision on the drug due by 26th Oc

News

Astellas extends protein degrader drive with Cullgen deal

Astellas has become the latest big pharma to pledge big bucks to a smaller company working on protein degraders, paying $35 million upfront to partner with US start-up Cul

News

AstraZeneca inks $2bn Treg cell therapy deal with Quell

UK start-up Quell Therapeutics has secured a partnership with AstraZeneca focused on cell therapies for autoimmune diseases, with an $85 million upfront payment and which

R&D

ASCO 2023 preview: Prioritising the exploration of patient d...

The American Society of Clinical Oncology (ASCO) annual meeting is approaching and provides the ideal setting to connect

News

ElevateBio cooks up $401m round, garnished with a Novo deal

Cell and gene therapy specialist ElevateBio has taken the total fundraising since it launched five years ago to around $1.25 billion, with its latest $401 million round th

News

Foundation aims to level health access with digital tech

A new initiative called the Movement Health Foundation (MHF) has been launched with a pledge to encourage greater use of digital technologies to equalise access to healthc

Catalyst throws lifeline to Santhera with $90m Duchenne deal

Astellas extends protein degrader drive with Cullgen deal

AstraZeneca inks $2bn Treg cell therapy deal with Quell

ASCO 2023 preview: Prioritising the exploration of patient d...

ElevateBio cooks up $401m round, garnished with a Novo deal

Foundation aims to level health access with digital tech

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

partnering

Editor's Picks